登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>CD47 >CD7-C52H1

Cynomolgus / Rhesus macaque CD47 Protein, His Tag

分子别名(Synonym)

CD47,MER6,IAP,OA3

表达区间及表达系统(Source)

Cynomolgus / Rhesus macaque CD47, His Tag (CD7-C52H1) is expressed from human 293 cells (HEK293). It contains AA Gln 19 - Glu 141 (Accession # F7A802-1). In the region Gln 19 - Glu 141, the AA sequence of Cynomolgus and Rhesus macaque CD47 are homologus.

Predicted N-terminus: Gln 19

Request for sequence

蛋白结构(Molecular Characterization)

CD47 Structure

This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 15.8 kDa. The protein migrates as 30-50 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

纯度(Purity)

>95% as determined by SDS-PAGE.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.

质量管理控制体系(QMS)

  1. 质量管理体系(ISO, GMP)
  2. 质量优势
  3. 质控流程
 

电泳(SDS-PAGE)

CD47 SDS-PAGE

Cynomolgus / Rhesus macaque CD47, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

 

活性(Bioactivity)-ELISA

CD47 ELISA

Immobilized Human SIRP alpha, Fc Tag (HPLC-verified) (Cat. No. SIA-H5251) at 5 μg/mL (100 μL/well) can bind Cynomolgus / Rhesus macaque CD47, His Tag (Cat. No. CD7-C52H1) with a linear range of 4-63 ng/mL (QC tested).

Protocol

CD47 ELISA

Immobilized Anti-CD47, Human IgG4 at 2 μg/mL (100 μL/well) can bind Cynomolgus / Rhesus macaque CD47, His Tag (Cat. No. CD7-C52H1) with a linear range of 0.2-5 ng/mL (Routinely tested).

Protocol

 

活性(Bioactivity)-SPR

CD47 SPR

Anti-CD47 Mab (Human IgG4) captured on CM5 chip via anti-human IgG Fc antibodies surface, can bind Cynomolgus/Rhesus macaque CD47, His Tag (Cat. No. CD7-C52H1) with an affinity constant of 1.8 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

Protocol

 

活性(Bioactivity)-BLI

CD47 BLI

Loaded Anti-Human CD47 MAb (Human IgG4) on AHC Biosensor, can bind Cynomolgus / Rhesus macaque CD47, His Tag (Cat. No. CD7-C52H1) with an affinity constant of 2.93 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol

 
评论(5)
  1. 136XXXXXXX0
  2. 0人赞
  3. 购买该蛋白用于免疫原对小鼠进行免疫,及抗体筛选用。该蛋白活性好,性质稳定,免疫小鼠得到较高的效价,用于抗体结合检测,也得到稳定可靠的结果。多次购买,批间差小,性质稳定。
  4. >
  5. 2023-3-15
  1. 136XXXXXXX0
  2. 0人赞
  3. 购买该蛋白用于抗体筛选实验。多次购买该蛋白,批间差稳定,经ELISA实验验证,可以得到稳定且可重复的实验结果。
  4. >
  5. 2023-1-31
  1. 188XXXXXXX5
  2. 0人赞
  3. 采购该靶点猴蛋白Cynomolgus / Rhesus macaque CD47, His Tag (CD7-C52H1)是用于杂交瘤抗体药物早期筛选与最终分子的人猴交叉反应验证,目前获得的人猴交叉抗体药物分子已经走到PCC阶段。我这边95%的蛋白是在ACRO采购的,以后也是~
  4. 2021-7-24
 
ACRO质量管理体系
 
 

背景(Background)

Leukocyte surface antigen CD47 is also known as Antigenic surface determinant protein OA3, Integrin-associated protein (IAP) and Protein MER6. CD47 contains 1 Ig-like V-type (immunoglobulin-like) domain. CD47 is very broadly distributed on normal adult tissues. CD47 has a role in both cell adhesion by acting as an adhesion receptor for THBS1 on platelets, and in the modulation of integrins and plays an important role in memory formation and synaptic plasticity in the hippocampus by similarity. CD47 is the receptor for SIRPA, binding to which prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells. CD47 Interaction with SIRPG mediates cell-cell adhesion, enhances superantigen-dependent T-cell-mediated proliferation and costimulates T-cell activation.

 

前沿进展

CD47 Contributes to the Proliferation of Breast Cancer
Wang, Wu, Liu et al
Front Biosci (Landmark Ed) (2025) 30 (3), 28210
Abstract: The CD47 molecule (CD47) performs a novel role in regulating immunoreactions by binding to signal-regulatory protein alpha (SIRPα), resulting in the tumorigenesis of multiple malignant neoplasms. However, its effects and mechanisms in breast cancer (BC) remain unknown.To explore the molecular mechanisms and explicit impacts of CD47, we screened two databases for CD47-associated signaling pathways and cellular functions. BC samples and patients' basic information were collected to identify the statistical significance of CD47 expression. We also constructed experiments to validate the regulatory role of CD47 in BC cell proliferation.Analysis of the TCGA-BRCA, GSE42568, and GSE15852 datasets demonstrated an elevated level of CD47 in BC tissues. A Venn diagram revealed 11,194 co-expressed genes, and pathway analysis linked elevated CD47 levels to critical signaling pathways, such as cytokine-receptor interactions and Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling, which are integral to cell proliferation and invasiveness. Clinical data from 108 BC specimens showed that CD47 localization was primarily membranous, with higher levels correlating with proliferation marker Ki-67 (Ki-67) expression (p < 0.0001) and advanced tumor/node/metastasis (TNM) stage (p < 0.0001). Additionally, functional assays demonstrated that CD47 depletion reduced cell viability (p < 0.01), migration (p < 0.001), and invasion (p < 0.05 in 4T1 cells; p < 0.001 in MDA-MB-231 cells) in vitro and led to smaller tumor volumes (p < 0.0001) in vivo.CD47 is a key regulator of BC cell proliferation and invasiveness and serves as a potential marker for assessing tumor aggressiveness and guiding therapeutic strategies.© 2025 The Author(s). Published by IMR Press.
Single-Cell Transcriptomics Identified Fibrosis-Activated Valve Interstitial Cells Involved in Functional Tricuspid Regurgitation
Zhao, Fu, Shu et al
JACC Asia (2025) 5 (3 Pt 2), 478-495
Abstract: The treatment of functional tricuspid regurgitation (TR) is still controversial. Characterizing the cellular composition of the tricuspid valve and identifying the molecular alterations of each cell type in valves with TR will advance our understanding of the mechanisms of TR and guide improvements in treatment.The authors aimed to investigate the changes in cellular composition and gene expression patterns of cells in regurgitant tricuspid valves and shed light on the mechanisms of functional TR.To improve our understanding of the pathogenesis of functional TR, we performed single-cell RNA sequencing of tricuspid valve from 10 patients, including 5 patients with moderate-to-severe functional TR and 5 nondiseased control subjects. Multiplexed fluorescence was used to detect the spatial distributions of valvular cell states and validated the cell-cell interaction.We assessed the transcriptional profiles of 84,102 cells and identified 6 major cell clusters, along with 25 cell subtypes, in the specimens. Valve interstitial cells (VICs) were the largest population. VICs and lymphoid cells exhibited more heterogeneity in TR patients. VICs exhibited higher transcriptional activity toward matrifibrocyte-like cells and myofibroblast-like cell differentiation, myeloid cells activated immune response, and lymphoid cells promoted fibrosis. In TR, the alternation of COMP-CD47 and FGF2-FGFR1 interaction may occur in TR specimens, which may serve as promising therapeutic targets for TR.Our single-cell atlas highlights the transcriptomic heterogeneity underlying the cell functions and interactions in human tricuspid valves and defines molecular and cellular perturbations in functional TR. We identified VIC clusters with fibrosis activation accumulated in TR valves.Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Dual blockade of GSTK1 and CD47 improves macrophage-mediated phagocytosis on cancer cells
Yu, Ye, Shi et al
Biochem Pharmacol (2025)
Abstract: CD47 is a crucial anti-phagocytic signal in regulating macrophage responses and its manipulation offers the therapeutic potential in cancer treatment. However, in many cases, blockade of CD47 by itself is insufficient to activate macrophage effectively, indicating other unidentified phagocytosis-regulating factors to resist the macrophage activity. In this study, a genome-wide human CRISPR-Cas9 library was developed for comprehensive screening of phagocytosis-regulating factors in the context of CD47 blockade. The screening results identified GSTK1 as a potential anti-phagocytic signal counteracting the efficacy of CD47-based phagocytosis. The disruption of GSTK1 significantly increased the phagocytosis rate of cancer cells by macrophages in combination with anti-CD47 antibody. Further mechanism investigation unveiled that GSTK1 blockade increased the membrane exposure of calreticulin in different cancer cells, which might be the primary mechanism driving enhanced macrophage-mediated phagocytosis. To this end, siGSTK1-loaded nanoparticles (siGSTK1-LNPs) were designed to suppress the GSTK1 expression efficiently. The comparable phagocytosis efficacy was also observed when combining siGSTK1-LNPs with anti-CD47 antibody. Above all, GSTK1 blockade was identified as a promising and feasible stimulus for enhancing the effectiveness of anti-CD47 antibody, introducing a novel and effective combination approach in cancer immunotherapy.Copyright © 2025. Published by Elsevier Inc.
Neuronal CD47 induces behavioral alterations and ameliorates microglial synaptic pruning in wild-type and Alzheimer's mouse models
Hu, Chen, Lin et al
Cell Biosci (2025) 15 (1), 38
Abstract: Microglia are brain-resident macrophages that play a crucial role in synapse pruning during the development and progression of various neuropsychiatric disorders, including autism spectrum disorder (ASD) and Alzheimer's disease (AD). Mechanistically, CD47 protein acts as a potent 'do not eat me' signal, protecting synapses from phagocytosis by microglia. However, the functional role of the upregulated neuronal CD47 signal under both physiological and pathological conditions remains unclear.We utilized an adeno-associated virus gene expression system to induce neuron-specific overexpression of CD47 in wild-type and 5xFAD mice, assessing its effects on microglial synaptic phagocytosis and mouse behaviors. Our results indicate that neuronal CD47 induces ASD-like behaviors and synaptic pruning defects, while promoting behavioral disinhibition and improving memory in wild-type mice. Single-nucleus RNA sequencing was employed to profile gene expression patterns in subpopulations of neurons and microglia. Notably, neuronal CD47 enhances synaptic pathways in neurons and particularly shifts microglial subpopulations from a disease-associated state to a homeostatic state. Additionally, neuronal CD47 reduces excessive microglial synaptic phagocytosis induced by Aβ pathology in 5xFAD mice.Our study provides evidence that neuronal CD47 overexpression results in synaptic pruning defects and is involved in the pathogenesis of ASD, while also playing a beneficial role in mitigating excessive synaptic loss in Alzheimer's disease.© 2025. The Author(s).
Showing 1-4 of 3060 papers.
Powered by BizGenius
 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
CD47靶点信息
英文全称:Cluster of differentiation 47
中文全称:分化群47
种类:Homo sapiens
上市药物数量:0详情
临床药物数量:57详情
最高研发阶段:临床三期
查看更多信息
前沿进展
点击查看详细

消息提示

请输入您的联系方式,再点击提交!

确定